Overview

A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability and efficacy of darifenacin, in the long-term treatment of adult patients with overactive bladder.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Darifenacin